86 related articles for article (PubMed ID: 3456091)
1. [Neurological complications of acute myeloid leukemia in adults].
Pagano L; Marra R; De Stefano V; Di Donfrancesco A; Leone G
Minerva Med; 1986 Jan; 77(1-2):13-7. PubMed ID: 3456091
[TBL] [Abstract][Full Text] [Related]
2. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
3. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
4. [Central nervous system irradiation for children with leukemia].
Chatani M; Teshimá T; Inoue T; Azuma I; Kumano M; Hishikawa Y; Kondo K; Tabata S; Suyama T; Yabumoto E
Gan No Rinsho; 1984 Feb; 30(2):152-6. PubMed ID: 6423857
[TBL] [Abstract][Full Text] [Related]
5. [Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms].
Grisold W; Mokrusa W; Mamoli B; Weber R; Lutz D
Wien Klin Wochenschr; 1985 Aug; 97(16):662-6. PubMed ID: 3864314
[TBL] [Abstract][Full Text] [Related]
6. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
8. Nervous system involvement in adult acute myeloid leukaemia: report of five cases.
Ruggero D; Baccarani M; Zaccaria A; Gobbi M; Tomasini I; Tura S
Haematologica; 1977 Jun; 62(3):312-9. PubMed ID: 408244
[No Abstract] [Full Text] [Related]
9. [Prophylactic central nervous system irradiation for childhood acute lymphoblastic leukemia].
Chatani M; Teshima T; Inoue T; Azuma I; Kumano M; Hishikawa Y; Kondo K; Suyama T; Yabumoto E; Nakajima T
Gan No Rinsho; 1984 Apr; 30(4):363-7. PubMed ID: 6587134
[TBL] [Abstract][Full Text] [Related]
10. [Comparative treatment of acute leukemia in adults].
Kubel M; Helbig W; Schultze W; Günther C; Schwenke H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):559-73. PubMed ID: 6162725
[TBL] [Abstract][Full Text] [Related]
11. [The frequency of central nervous system manifestations in adult acute leukemia].
Neumann E; Mittermayer K; Budka H; Honetz H; Schwarzmeier J
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():654-6. PubMed ID: 1072334
[No Abstract] [Full Text] [Related]
12. Tuberculous meningitis--its neurological complications with special reference to their prognostic significance.
Mehrotra MP; Pursnani ML; Patney NL; Tandon RK; Jain RK
J Assoc Physicians India; 1982 Dec; 30(12):869-73. PubMed ID: 7184910
[No Abstract] [Full Text] [Related]
13. [Central nervous system involvement in adult acute leukemia].
Sasaki H; Maekawa I; Kawamura S; Miyake T
Gan No Rinsho; 1984 Mar; 30(3):221-5. PubMed ID: 6585574
[TBL] [Abstract][Full Text] [Related]
14. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleukemia in adults].
Beslać-Bumbasirević Lj; Bosković D; Tomin D; Colović M; Kovacević M; Bumbasirević V
Srp Arh Celok Lek; 1996; 124(3-4):82-6. PubMed ID: 9102825
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of elderly patients with acute myeloid leukemia].
Löwenberg B
Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2157-9. PubMed ID: 9550795
[TBL] [Abstract][Full Text] [Related]
18. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
19. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
[TBL] [Abstract][Full Text] [Related]
20. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
